CeriBell, Inc.

US$26.59As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CBLLHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR 0.56%
Div yield —
ROE (52.47%)
Medical Devices
Beta (5Y) 0.86
PE TTM —
TSR TTM 133.25%
Mkt cap US$1.033B
ROIC (29.22%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$32
20.28%
(43.02%)
Hold 3|7|12|12|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.33
0.33
0.33
0.35
17.52%
11.20%
18.59%
21.23%
Revenue$M
50.72
49.58
50.42
48.95
0.09%
0.57%
0.31%
(1.78%)
Peers (US$1.033B)
Cap (US$)
PE
986.0M
—
979.2M
—
1.041B
15.52x
Capital
TTM
5Y
10Y
Leveragex
2.208
0.363
0.283
EBIT/Intx
0.113
1.033
0.870
Own earn%
(118.84)
(11.28)
(15.34)
Sh yield%
35.80
29.12
28.97
Owners
Insiders/Inst%
4.45
63.14
Short interest%
5.68
SBC / revenue%
5.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
28–32
$1 testx
—
Incr. ROIC%
5